DE3585790D1 - Varicella-zoster-virus-dns-sequenzen, diese enthaltende vektoren und wirtzellen, uebereinstimmende polypeptide und diese enthaltende verbindungen. - Google Patents

Varicella-zoster-virus-dns-sequenzen, diese enthaltende vektoren und wirtzellen, uebereinstimmende polypeptide und diese enthaltende verbindungen.

Info

Publication number
DE3585790D1
DE3585790D1 DE8585401657T DE3585790T DE3585790D1 DE 3585790 D1 DE3585790 D1 DE 3585790D1 DE 8585401657 T DE8585401657 T DE 8585401657T DE 3585790 T DE3585790 T DE 3585790T DE 3585790 D1 DE3585790 D1 DE 3585790D1
Authority
DE
Germany
Prior art keywords
vectors
compounds
host cells
dna sequences
zoster virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585401657T
Other languages
English (en)
Inventor
Ronald W Ellis
Paul M Keller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE3585790D1 publication Critical patent/DE3585790D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DE8585401657T 1984-08-21 1985-08-19 Varicella-zoster-virus-dns-sequenzen, diese enthaltende vektoren und wirtzellen, uebereinstimmende polypeptide und diese enthaltende verbindungen. Expired - Fee Related DE3585790D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/642,983 US4769239A (en) 1984-08-21 1984-08-21 Vaccine against varicella-zoster virus

Publications (1)

Publication Number Publication Date
DE3585790D1 true DE3585790D1 (de) 1992-05-07

Family

ID=24578863

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585401657T Expired - Fee Related DE3585790D1 (de) 1984-08-21 1985-08-19 Varicella-zoster-virus-dns-sequenzen, diese enthaltende vektoren und wirtzellen, uebereinstimmende polypeptide und diese enthaltende verbindungen.

Country Status (6)

Country Link
US (1) US4769239A (de)
EP (1) EP0192902B1 (de)
JP (1) JP2597542B2 (de)
CA (1) CA1272456A (de)
DE (1) DE3585790D1 (de)
HK (1) HK8297A (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260012A1 (de) * 1986-09-02 1988-03-16 Merck & Co. Inc. Promotor zur Expression von heterologenen Proteinen in Säugetierzellen
US5169836A (en) * 1988-11-10 1992-12-08 Trustees Of The University Of Penna. Inhibitors of platelet binding
CY1933A (en) * 1989-06-27 1990-06-22 Smithkline Biolog Novel compounds
KR920703614A (ko) * 1990-10-04 1992-12-18 티모시 제이. 렉카르트 바리셀라-조스터 바이러스 항원
US5824319A (en) * 1990-10-04 1998-10-20 Research Corporation Technologies, Inc. Varicella-zoster virus antigen
ATE210722T1 (de) 1992-07-17 2001-12-15 Merck & Co Inc Methode zur verhinderung von zoster und linderung der mit varicellea verbundenen postherpetischen neuralgie
US5728386A (en) * 1993-12-21 1998-03-17 Merck & Co., Inc. Thermostable varicella zoster virus
AU2361495A (en) * 1994-04-28 1995-11-29 Aviron A novel vzv gene, mutant vzv and immunogenic compositions
KR970006484A (ko) * 1995-07-27 1997-02-21 수두 바이러스의 당단백질을 대량발현시키는 동물세포주
GB0504436D0 (en) 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
GB201116248D0 (en) 2011-09-20 2011-11-02 Glaxosmithkline Biolog Sa Liposome production using isopropanol
US10232035B2 (en) 2012-09-14 2019-03-19 The Regents Of The University Of Colorado, A Body Corporate Conditionally replication deficient herpes virus and use thereof in vaccines
KR20180077180A (ko) 2015-11-06 2018-07-06 아쥬반스 테크놀로지스 인코포레이티드 트리테르펜 사포닌 유사체
WO2017177204A1 (en) * 2016-04-09 2017-10-12 La Jolla Institute For Allergy And Immunology Leveraging immune memory from common childhood vaccines to fight disease
BE1025160B1 (fr) 2016-12-07 2018-11-26 Glaxosmithkline Biologicals Sa Nouveau procédé
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
WO2018198085A1 (en) 2017-04-28 2018-11-01 Glaxosmithkline Biologicals Sa Vaccination
US12016919B2 (en) 2017-05-30 2024-06-25 Glaxosmithkline Biologicals Sa Methods for manufacturing an adjuvant
CA3083078A1 (en) 2017-12-01 2019-06-06 Glaxosmithkline Biologicals Sa Saponin purification
US20210283238A1 (en) 2018-08-07 2021-09-16 Glaxosmithkline Biologicals Sa Novel processes and vaccines
EP3886901A1 (de) 2018-11-29 2021-10-06 GlaxoSmithKline Biologicals S.A. Verfahren zur herstellung eines adjuvans
JP2022535091A (ja) 2019-06-05 2022-08-04 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム サポニン精製
CN112142829B (zh) * 2019-06-28 2022-02-22 怡道生物科技(苏州)有限公司 水痘-带状疱疹病毒gE蛋白突变体及其表达方法
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD147855A5 (de) * 1978-12-22 1981-04-22 Biogen Nv Verfahren zur erzeugung mindestens eines hbv-antigenwirkung aufweisenden polypeptids
EP0211756A1 (de) * 1985-08-01 1987-02-25 Merck & Co. Inc. Assay für Varicella-Zoster-Virus (VZV)-Antikörper

Also Published As

Publication number Publication date
HK8297A (en) 1997-01-24
JPS6181792A (ja) 1986-04-25
US4769239A (en) 1988-09-06
JP2597542B2 (ja) 1997-04-09
EP0192902A2 (de) 1986-09-03
EP0192902B1 (de) 1992-04-01
EP0192902A3 (en) 1987-09-02
CA1272456A (en) 1990-08-07

Similar Documents

Publication Publication Date Title
DE3585790D1 (de) Varicella-zoster-virus-dns-sequenzen, diese enthaltende vektoren und wirtzellen, uebereinstimmende polypeptide und diese enthaltende verbindungen.
DK73483D0 (da) Dna-sekvenser, rekombinant-dna-molekyler samt fremgangsmader til fremstilling af human-immune interferonlignende polypeptider
DE3587864D1 (de) Rekombinant-dns-moleküle.
GB8628313D0 (en) Dna rna peptides/polypeptides
ES2137931T3 (es) Proteinas gdf-1 y uog-1.
FI871124A (fi) Polypeptid, dna och dess anvaendning.
DE3750106D1 (de) Rekombinanter B-Zell-Differenzierungsfaktor.
DK375283A (da) Dna-sekvenser, rekombinations-dna-molekyler samt fremgangsmaader til fremstilling af kvaegvaeksthormonlignende polypeptider
DK374087D0 (da) Fremgangsmaade til fremstilling af proteiner med faktor viii-aktivitet ved hjaelp af mikrobielle voertsceller og ekspressionsvektorer, vaertsceller og antistoffer til anvendelse ved denne
DE68924227D1 (de) DNA-Fragment.
AU9013082A (en) Rec. dna stabilised host cells with lambda phage fragment
DK54184A (da) Dna-sekvenser, rekombinations-dna-molekyler samt fremgangsmaader til fremstilling af human (interleukin) to-lignende polypeptider
DE3786649D1 (de) Pferde-gamma-interferon.
NO174970C (no) Rekombinant DNA, rekombinant DNA-vektor samt vertscelle
DE3576524D1 (de) Dna-sequenzen.
ES545725A0 (es) Procedimiento para preparar peptidos de interferon
FI841288A (fi) Rekombinant-dna-kod foer uttryckning av polypeptid.
GB2182043A (en) Precursor polypeptide dna sequence coding therefor, vectors, host organisms and processes involving same
GB8404378D0 (en) Dna sequence recombinant dna molecules
NO860550L (no) Polypeptider av rhinovirus, samt dna-molekyler som koder for slike.
DK420487D0 (da) Nucleinsyresekvens, der koder for en carcinoembryonisk antigenpeptid-sekvens
ATE63462T1 (de) Vakzinale polypeptide.
NO871038D0 (no) Dna-fragment.
DK161487D0 (da) Alfa-interferon-analoge og fremgangsmaade til fremstilling deraf samt udtrykkelsesvektorer og vaertsorganismer til anvendelse ved fremgangsmaaden.
PT676413E (pt) Proteina de ligacao a interferoes alfa/beta, sua preparacao e utilizacao

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee